Irja Lutsar

7.7k total citations · 1 hit paper
152 papers, 4.8k citations indexed

About

Irja Lutsar is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Irja Lutsar has authored 152 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Infectious Diseases, 60 papers in Epidemiology and 37 papers in Pharmacology. Recurrent topics in Irja Lutsar's work include Antibiotics Pharmacokinetics and Efficacy (37 papers), Pharmaceutical studies and practices (27 papers) and Pneumonia and Respiratory Infections (26 papers). Irja Lutsar is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (37 papers), Pharmaceutical studies and practices (27 papers) and Pneumonia and Respiratory Infections (26 papers). Irja Lutsar collaborates with scholars based in Estonia, United Kingdom and United States. Irja Lutsar's co-authors include Tuuli Metsvaht, Thomas J. Walsh, Ian R. Friedland, B. Dupont, Peter F. Troke, Peter A. Milligan, George H. McCracken, Mats O. Karlsson, Kieren A. Marr and Timothy Driscoll and has published in prestigious journals such as PLoS ONE, Advanced Drug Delivery Reviews and Clinical Infectious Diseases.

In The Last Decade

Irja Lutsar

147 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

2003 508 citations Irja Lutsar et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Irja Lutsar Estonia	34	2.6k	2.6k	894	620	610	152	4.8k
Antonio Arrieta United States	30	2.0k 0.8×	1.9k 0.7×	901 1.0×	351 0.6×	512 0.8×	110	3.6k
Pranatharthi Chandrasekar United States	43	4.8k 1.8×	4.3k 1.7×	732 0.8×	228 0.4×	419 0.7×	160	7.1k
Didier Guillemot France	39	1.3k 0.5×	2.3k 0.9×	443 0.5×	159 0.3×	354 0.6×	167	5.0k
Deborah Marriott Australia	47	4.3k 1.6×	3.0k 1.2×	1.3k 1.4×	138 0.2×	324 0.5×	149	6.8k
Michael Neely United States	38	2.7k 1.0×	2.4k 0.9×	3.4k 3.8×	866 1.4×	398 0.7×	178	6.7k
Richard F. Jacobs United States	39	2.3k 0.9×	3.3k 1.3×	426 0.5×	751 1.2×	685 1.1×	136	5.4k
Dafna Yahav Israel	41	1.6k 0.6×	1.8k 0.7×	1.1k 1.2×	186 0.3×	442 0.7×	207	5.5k
Ellen Jo Baron United States	32	1.7k 0.6×	2.0k 0.8×	544 0.6×	109 0.2×	605 1.0×	94	5.4k
Mindy G. Schuster United States	25	5.5k 2.1×	4.6k 1.8×	603 0.7×	118 0.2×	293 0.5×	56	6.9k
Linda M. Mundy United States	37	2.3k 0.9×	2.6k 1.0×	393 0.4×	149 0.2×	312 0.5×	117	5.1k

Countries citing papers authored by Irja Lutsar

Since Specialization

Citations

This map shows the geographic impact of Irja Lutsar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irja Lutsar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irja Lutsar more than expected).

Fields of papers citing papers by Irja Lutsar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irja Lutsar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irja Lutsar. The network helps show where Irja Lutsar may publish in the future.

Co-authorship network of co-authors of Irja Lutsar

This figure shows the co-authorship network connecting the top 25 collaborators of Irja Lutsar. A scholar is included among the top collaborators of Irja Lutsar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irja Lutsar. Irja Lutsar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Soeorg, Hiie, Aare Abroi, Paul Naaber, et al.. (2024). Dynamics of SARS-CoV-2 lineages in children and adults in 2021 and 2022. PLoS ONE. 19(12). e0316213–e0316213.

Soeorg, Hiie, Mari‐Liis Ilmoja, Koit Herodes, et al.. (2023). Prediction of C‐reactive protein dynamics during meropenem treatment in neonates and infants. British Journal of Clinical Pharmacology. 90(3). 801–811. 1 indexed citations

Zilmer, Kai, et al.. (2023). No transmitted drug resistance to HIV integrase strand-transfer inhibitors after their scale-up in Estonia in 2017. Journal of Global Antimicrobial Resistance. 33. 83–88. 2 indexed citations

Abroi, Aare, Ulvi Gerst Talas, Tuuli Reisberg, et al.. (2022). SARS-CoV-2 dual infection with Delta and Omicron variants in an immunocompetent host: a case report. International Journal of Infectious Diseases. 124. 41–44. 1 indexed citations

Lutsar, Irja, Begonya Nafría, Stefanie Breitenstein, et al.. (2022). Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children. Clinical and Translational Science. 16(3). 478–488. 6 indexed citations

Geller, Julia, et al.. (2021). Norovirus strains among children aged 0–18 years hospitalized with acute gastroenteritis in Estonia 2015–2016. Journal of Medical Virology. 94(6). 2632–2639. 4 indexed citations

Avi, Radko, et al.. (2021). Dynamics of hepatitis C epidemic among people living with HIV in Estonia based on Estonian HIV cohort study. BMC Infectious Diseases. 21(1). 792–792. 2 indexed citations

Williams, Phoebe, John S. Bradley, Emmanuel Roilides, et al.. (2021). Harmonising regulatory approval for antibiotics in children. The Lancet Child & Adolescent Health. 5(2). 96–98. 13 indexed citations

Hill, L., M. Turner, Irja Lutsar, et al.. (2020). An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial. Trials. 21(1). 329–329. 8 indexed citations

10.

Jacqz-Aigrain, Évelyne, Stéphanie Leroux, Alison H. Thomson, et al.. (2019). Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants. Journal of Antimicrobial Chemotherapy. 74(8). 2128–2138. 35 indexed citations

11.

Oona, Marje, et al.. (2017). Pertussis and parapertussis in children and adults with a persistent cough: an observational study. Infection. 46(1). 83–91. 9 indexed citations

12.

Huik, Kristi, Silver Türk, Don C. Des Jarlais, et al.. (2016). T Cell Distribution in Relation to HIV/HBV/HCV Coinfections and Intravenous Drug Use. Viral Immunology. 29(8). 464–470. 7 indexed citations

13.

Folgori, Laura, Julia Bielicki, M. Turner, et al.. (2016). Harmonisation in study design and outcomes in paediatric antibiotic clinical trials: a systematic review. The Lancet Infectious Diseases. 16(9). e178–e189. 13 indexed citations

14.

Huik, Kristi, Silver Türk, Don Des Jarlais, et al.. (2015). Differences in T cell distribution and CCR5 expression in HIV-positive and HIV-exposed seronegative persons who inject drugs. Medical Microbiology and Immunology. 205(3). 231–239. 7 indexed citations

15.

Parm, Ülle, Tuuli Metsvaht, Mari‐Liis Ilmoja, & Irja Lutsar. (2015). Gut colonization by aerobic microorganisms is associated with route and type of nutrition in premature neonates. Nutrition Research. 35(6). 496–503. 22 indexed citations

16.

Lutsar, Irja, Jelena Štšepetova, Ülle Parm, et al.. (2014). The development of gut microbiota in critically ill extremely low birth weight infants assessed with 16S rRNA gene based sequencing. Gut Microbes. 5(3). 304–503. 39 indexed citations

17.

Avi, Radko, et al.. (2013). Transmitted Drug Resistance Is Still Low in Newly Diagnosed Human Immunodeficiency Virus Type 1 CRF06_cpx-Infected Patients in Estonia in 2010. AIDS Research and Human Retroviruses. 30(3). 278–283. 10 indexed citations

18.

Esposito, Susanna, Robert Cohen, Javier Díez‐Domingo, et al.. (2012). Do We Know When, What and For How Long to Treat?. The Pediatric Infectious Disease Journal. 31(6). e78–e85. 87 indexed citations

19.

Avi, Radko, et al.. (2010). Characterization of Integrase Region Polymorphisms in HIV Type 1 CRF06_cpx Viruses in Treatment-Naive Patients in Estonia. AIDS Research and Human Retroviruses. 26(10). 1109–1113. 9 indexed citations

20.

Tamm, Eda, Paul Naaber, Matti Maimets, et al.. (2007). Antimicrobial susceptibility and serogroup/serotype distribution of nasopharyngeal isolates of Streptococcus pneumoniae in healthy Estonian children in 1999–2003. Clinical Microbiology and Infection. 13(8). 824–826. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact